An NYSE Scalper's Tale - A Trader's Diary

Monday, December 18, 2006

On Tap For Tue Dec 19, 2006

The following are some of the NYSE stocks that I will be keeping an eye on and possibly trading tomorrow. Obviously there may be news on other stocks that come out overnight or in the morning, so I may be trading those stocks as well.

Here's my list:

Labels: ,

2 Comments:

  • Eli Lilly Zyprexa scandal

    Zyprexa off label promotion scandal is all over the news now.
    Lilly drug reps are alleged to have called their marketing ploy,"Viva zyprexa".

    Eli Lilly zyprexa cost me over $250.00 a month supply out of my own pocket X 4 years and has up to ten times the risk (over non users) of causing diabetes and severe weight gain.

    Zyprexa which is only FDA approved for schizophrenia (.5-1% of pop) and some bipolar (2% pop) and then an even smaller percentage of theses two groups.
    So how does Zyprexa get to be the 7th largest drug sale in the world?
    Eli Lilly is in deep trouble for using their drug reps to 'encourage' doctors to write zyprexa for non-FDA approved 'off label' uses.

    The drug causes increased diabetes risk,and medicare picks up all the expensive fallout.There are now 7 states (and counting) going after Lilly for fraud and restitution.

    Only 9 percent of adult Americans think the pharmaceutical industry can be trusted right around the same rating as big tobacco.

    ---
    Daniel Haszard zyprexa-victims.com

    By Anonymous Daniel Haszard, at December 19, 2006 5:14 AM  

  • Daniel,
    Thanks for your comments and thanks for the update. In fact, I'd encourage more people like yourself to add their take on stocks in the news - especially in my On Tap posts so that others can get a clearer picture of what's going on.

    Best of luck to you!

    By Blogger J.C., at December 19, 2006 7:18 AM  

Post a Comment

<< Home